Hiroya Yamada   Koji Suzuki   Naohiro Ichino   Yoshitaka Ando   Akira Sawada   Keisuke Osakabe   Keiko Sugimoto   Koji Ohashi   Ryouji Teradaira   Takashi Inoue   Nobuyuki Hamajima   Shuji Hashimoto   
Clinica chimica acta; international journal of clinical chemistry 424 99-103 2013年9月 [査読有り]
BACKGROUND: In many industrialized countries, non-alcoholic fatty liver disease (NAFLD) is recognized as an important disease that increases the risk of cardiovascular disease, type-2 diabetes, and metabolic syndrome. Most people with NAFLD are as...